TrialToxins2018

AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study.

Roberto Eleopra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.